Severe Late-Onset Kawasaki Disease Successfully Treated With Anakinra

J Clin Rheumatol. 2020 Mar;26(2):e42-e43. doi: 10.1097/RHU.0000000000000814.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Age of Onset
  • Anticoagulants / administration & dosage
  • Antirheumatic Agents / administration & dosage
  • Aspirin / administration & dosage*
  • Computed Tomography Angiography / methods*
  • Coronary Aneurysm* / diagnostic imaging
  • Coronary Aneurysm* / etiology
  • Humans
  • Image Processing, Computer-Assisted / methods*
  • Immunoglobulins, Intravenous / administration & dosage*
  • Interleukin 1 Receptor Antagonist Protein / administration & dosage*
  • Male
  • Mucocutaneous Lymph Node Syndrome* / blood
  • Mucocutaneous Lymph Node Syndrome* / epidemiology
  • Mucocutaneous Lymph Node Syndrome* / physiopathology
  • Mucocutaneous Lymph Node Syndrome* / therapy
  • Treatment Outcome

Substances

  • Anticoagulants
  • Antirheumatic Agents
  • Immunoglobulins, Intravenous
  • Interleukin 1 Receptor Antagonist Protein
  • Aspirin